Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …

There is a current imperative to unravel the hierarchy of molecular pathways that drive the
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …

Objectives To unravel the hierarchy of cellular/molecular pathways in the disease tissue of
early, treatment-naïve rheumatoid arthritis (RA) patients and determine their relationship with …

This review takes stock of the global health governance (GHG) literature. We address the
transition from international health governance (IHG) to global health governance, identify …

Objective To define the relationship of synovial B cells to clinical phenotypes at different stages
of disease evolution and drug exposure in rheumatoid arthritis ( RA ). Methods Synovial …

Introduction Neovascularization contributes to the development of sustained synovial
inflammation in the early stages of Rheumatoid Arthritis. Ultrasound (US) provides an indirect …

Background Despite highly effective targeted therapies for rheumatoid arthritis, about 40%
of patients respond poorly, and predictive biomarkers for treatment choices are lacking. We …

Objective To examine in a cohort of rheumatoid arthritis (RA) patients undergoing serial
ultrasound (US)–guided biopsies of small joints in the context of clinical trials whether sufficient …

Objective: To investigate the response to biologic drugs in psoriatic arthritis and to quantify
non-response and outcome from switching agents. Methods: 60 patients (33 men and 27 …

Background Individuals with serum antibodies to citrullinated protein antigens (ACPA),
rheumatoid factor, and symptoms, such as inflammatory joint pain, are at high risk of developing …